10 likes | 69 Views
Discover how different radionuclides deliver varying absorbed doses to the renal cortex for maximum therapeutic benefit, with a focus on achieving a Tumor Control Probability of 0.9. Explore the implications of specific activities like 177Lu, 125Sn, and 177Y on treatment outcomes.
E N D
≈250Gy 200Gy ≈ tumor specific activity giving TCP=0.9 [MBq/ml] ≈130Gy 0.00 0.00 1.00 1.00 0.20 0.80 0.20 0.80 0.60 0.60 0.40 0.40 0.60 0.40 0.40 0.60 0.80 0.20 0.80 0.20 0.00 0.00 1.00 1.00 90Y 177Lu 125Sn renal cortex absorbed dosefraction per radionuclide (BED=33Gy)